Pharma4ever A/S: Financial statements 2017
CVR: 36436573
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Pharma4ever A/S (CVR 36436573) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 12,318,461 and a net result of DKK 1,708,287 compared with DKK 3,216,507 the year before. That is a decrease of 28.2% compared with the year before. Equity in the 2017 report amounted to DKK 1,465,884. The solvency ratio was 31.9%. The company had 8 employees in the financial year.
- Gross Profit
- DKK 12,318,461
- Profit/Loss
- DKK 1,708,287
- Equity
- DKK 1,465,884
- Total Assets
- DKK 4,592,958
- Employees
- 8
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 12.3 mio. | 1.7 mio. | 1.5 mio. | 8 |
| 2016 | - | 17.2 mio. | 3.2 mio. | 2.7 mio. | 9 |
Official annual report
Keep an eye on Pharma4ever A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of October 24, 2017, RGH af 1. november 2024 A/S has been appointed auditor of Pharma4ever A/S.
As of October 24, 2017, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Pharma4ever A/S.
Pharma4ever A/S has published its annual report for 2016. Gross profit came to DKK 17,154,329, and the net result was DKK 3,216,507.
About Pharma4ever A/S
Pharma4ever A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 2014. The company is registered under the industry Anden teknisk rådgivning. The company was previously named PHARMA4EVER ApS. The management consists of Bo Hejgaard Pedersen and Per Rønsholt Andresen. The board consists of Jonas Mortensen Højslet (chair), Per Rønsholt Andresen and Susanne Andersen. The company is owned by BHP Holding ApS and Andresen Holding af 29. maj 2015 ApS. The company has 6 employees (2018). In 2025, the company reported a gross profit of DKK 16,332,858 and a net result of DKK 2,714,802 compared with DKK 2,416,208 the year before. Equity in the 2025 report amounted to DKK 3,214,802.